Archives of Digestive Disorders

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-1518081136

Short Communication - Archives of Digestive Disorders (2025) Volume 7, Issue 3

Gut microbiome: Influencing health, disease, therapy

John Carter*

Department of Nutrition and GI Health, Johns Hopkins University, USA

*Corresponding Author:
John Carter
Department of Nutrition and GI Health
Johns Hopkins University, USA.
E-mail: jmcarr@jhu.edu

Received : 20-Jul-2025, Manuscript No. AAADD-25-220; Editor assigned : 22-Jul-2025, PreQC No. AAADD-25-220(PQ); Reviewed : 11-Aug-2025, QC No AAADD-25-220; Revised : 20-Aug-2025, Manuscript No. AAADD-25-220(R); Published : 29-Aug-2025 , DOI : 10.35841/ aaadd-7.3.220

Citation: Carter J. Gut microbiome: Influencing health, disease, therapie. Arch Dig Disord. 2025;07(03):220.

Visit for more related articles at Archives of Digestive Disorders

Introduction

The gut microbiome plays a critical role in modulating immune responses and its profound impact on the development and progression of inflammatory diseases. It discusses how microbial dysbiosis can lead to chronic inflammation, affecting various organ systems beyond the gut. The review emphasizes the potential for microbiome-targeted therapies to restore immune homeostasis and treat inflammatory conditions [1].

This review explores the intricate bidirectional communication pathway known as the gut-brain axis, particularly its involvement in neurodegenerative diseases. It delves into how gut microbiota dysbiosis can influence brain function, neuroinflammation, and ultimately contribute to conditions like Alzheimer's and Parkinson's disease. The article suggests that targeting the gut microbiome could offer novel therapeutic strategies for these debilitating disorders [2].

This paper investigates the complex interplay between dietary fiber intake and the gut microbiota, highlighting how different types of fibers influence microbial composition and metabolic activities. It discusses the production of short-chain fatty acids (SCFAs) by fiber fermentation and their diverse health benefits, including immune modulation and improved gut barrier function. The authors underscore the clinical relevance of fiber supplementation in managing various metabolic and inflammatory conditions [3].

This comprehensive review evaluates the current scientific evidence regarding the efficacy of probiotics in maintaining gut health and managing various diseases. It differentiates between specific probiotic strains and their mechanisms of action, such as modulating immune responses, improving gut barrier integrity, and competing with pathogens. The article highlights the importance of personalized approaches to probiotic supplementation, considering the diverse effects across different individuals and conditions [4].

This article explores the profound connection between the gut microbiota and metabolic syndrome, outlining the mechanisms through which microbial dysbiosis contributes to obesity, insulin resistance, dyslipidemia, and hypertension. It discusses the role of microbial metabolites, such as short-chain fatty acids and bile acids, in regulating host metabolism. The authors suggest that modulating the gut microbiota offers promising avenues for preventing and treating metabolic syndrome [5].

This paper investigates the role of gut microbiota dysbiosis in the pathogenesis of autoimmune diseases, with a particular focus on Systemic Lupus Erythematosus (SLE). It explains how alterations in microbial composition and function can contribute to immune dysregulation, loss of self-tolerance, and inflammatory responses characteristic of autoimmune conditions. The review suggests that therapeutic interventions targeting the gut microbiome could offer novel strategies for managing these complex diseases [6].

This article explores the current understanding and future potential of prebiotics in promoting gut health. It details how prebiotics, as non-digestible food ingredients, selectively stimulate the growth and activity of beneficial gut bacteria, leading to various health benefits. The review discusses their impact on gut barrier function, immune modulation, and metabolic health, providing insights into their therapeutic applications and areas for future research [7].

This review focuses on the critical role of the intestinal barrier in maintaining gut health and preventing disease. It elaborates on the key components regulating barrier integrity, including tight junctions, mucus layer, and immune cells. The article discusses how disruptions in this barrier can lead to increased permeability, contributing to various inflammatory and autoimmune conditions, and highlights potential therapeutic strategies to restore its function [8].

This review explores the intricate relationship between stress, the gut microbiota, and the brain, emphasizing its profound implications for mental health. It elucidates how psychological stress can induce alterations in gut microbial composition and function, leading to dysbiosis, which in turn affects neuroinflammation and neurotransmitter systems. The article suggests that interventions targeting the gut microbiome could offer novel strategies for managing stress-related mental disorders [9].

This review explores the emerging field of personalized nutrition, specifically leveraging individual gut microbiota profiles to optimize dietary recommendations for improved health outcomes. It discusses how inter-individual variations in microbial composition influence nutrient metabolism and response to different foods. The article highlights the potential of microbiota-guided dietary interventions to prevent and manage various diseases, emphasizing the shift from "one-size-fits-all" to highly tailored nutritional strategies [10].

 

Conclusion

The gut microbiome plays a foundational role in human health, critically modulating immune responses and significantly influencing the development and progression of inflammatory diseases. Disruptions in this microbial balance, known as dysbiosis, are linked to chronic inflammation that can affect various organ systems beyond the gut. This intricate microbial community also forms a crucial component of the gut-brain axis, a bidirectional communication pathway. Dysbiosis in this axis has profound implications for neurological health, contributing to neuroinflammation and conditions like Alzheimer's and Parkinson's disease, and exacerbating stress-related mental disorders. Beyond inflammation and neurological impacts, the gut microbiota is deeply connected to metabolic syndrome. Microbial dysbiosis contributes to key features such as obesity, insulin resistance, dyslipidemia, and hypertension, often mediated by metabolites like short-chain fatty acids and bile acids. Therapeutic strategies often involve dietary adjustments. Dietary fibers, for instance, significantly influence gut microbial composition and metabolism, leading to the production of beneficial short-chain fatty acids that support immune modulation and gut barrier function. Probiotics, specific beneficial microbial strains, are also evaluated for their efficacy in maintaining gut health, improving barrier integrity, and modulating immune responses. Similarly, prebiotics, non-digestible food ingredients, selectively foster the growth of beneficial gut bacteria, contributing to improved gut barrier function, immune regulation, and overall metabolic health. The integrity of the intestinal barrier itself is vital; disruptions in this barrier increase permeability, linking to a range of inflammatory and autoimmune conditions like Systemic Lupus Erythematosus. Looking forward, the potential of personalized nutrition, guided by individual gut microbiota profiles, is gaining traction. This approach aims to optimize dietary recommendations for better health outcomes, acknowledging the unique variations in how individuals metabolize nutrients and respond to food, thus offering tailored strategies for disease prevention and management.

References

    1. Hao Y, Kexin M, Peng D. The Gut Microbiome: A Key Regulator of Immune Cell Functions and Inflammatory Diseases. Front Immunol. 2024;15(-):1354784.

Indexed at, Google Scholar, Crossref

    1. Huimin W, Weichen C, Tingting H. The Gut-Brain Axis: A Bidirectional Link between Microbiota and Neurodegenerative Diseases. J Clin Med. 2023;12(10):3598.

Indexed at, Google Scholar, Crossref

    1. Linlin L, Zhenyu P, Haiying H. Dietary Fiber and the Gut Microbiota: Recent Insights and Clinical Implications. Nutrients. 2022;14(24):5353.

Indexed at, Google Scholar, Crossref

    1. Seong HK, Jae HL, Young BO. Probiotics in Gut Health and Disease: A Review of Current Evidence. Nutrients. 2021;13(2):614.

Indexed at, Google Scholar, Crossref

    1. Min F, Jing L, Yating G. The Gut Microbiota and Metabolic Syndrome: Mechanisms and Therapeutic Opportunities. Front Cell Infect Microbiol. 2023;13(-):1206969.

Indexed at, Google Scholar, Crossref

    1. Jia L, Jian C, Di Z. Gut Microbiota Dysbiosis in Autoimmune Diseases: A Focus on Systemic Lupus Erythematosus. Cells. 2023;12(6):931.

Indexed at, Google Scholar, Crossref

    1. Young ML, Kyoung SK, So EL. Prebiotics for Gut Health: Current Evidence and Future Perspectives. Nutrients. 2022;14(14):2921.

Indexed at, Google Scholar, Crossref

    1. J. AO, Nabeel NA, Shukran MF. Intestinal Barrier Function: Key Regulators and Therapeutic Interventions. J Inflamm Res. 2024;17(-):635-649.

Indexed at, Google Scholar, Crossref

    1. Soo NK, Keon HL, Min HP. Stress and the Gut Microbiota-Brain Axis: Implications for Mental Health. Exp Neurobiol. 2021;30(5):437-449.

Indexed at, Google Scholar, Crossref

    1. Xiaowei W, Chun L, Jian W. Personalized Nutrition Approaches Based on Gut Microbiota: A Review. Front Nutr. 2023;10(-):1118749.

Indexed at, Google Scholar, Crossref

Get the App